Histopathologic and Radiologic Assessment of Chemotherapeutic Response in Ewing's Sarcoma: A Review

Abstract EN

Ewing’s sarcoma is a highly malignant tumor that metastasizes rapidly and is thus associated with a low survival rate.

The intensification of chemotherapy has been shown to improve the overall survival of patients with Ewing’s sarcoma.

However, intensified chemotherapy can lead to increased toxicity or even the development of secondary malignancies.

The stratification of patients with Ewing’s sarcoma into “good” and “poor” responders may help guide the administration of progressively more intensified chemotherapy.

Thus, an accurate assessment of the chemotherapeutic response, as well as the extent of chemotherapy-induced tumor necrosis, is critical for avoiding potential treatment-related complications in these patients.

This paper reviews the methods currently used to evaluate chemotherapeutic response in Ewing’s sarcoma, focusing specifically on histopathologic and imaging analyses, and discusses novel therapies and imaging methods that may help improve the overall survival of these patients.